Academic Journal
Q1EPMA Journal
About EPMA Journal
EPMA Journal is a scholarly journal published by Springer Science and Business Media Deutschland GmbH. SCImago 2025 lists it in Q1, with an SJR of 1.545 and H-index of 64.
Coverage: 2010-2026. Research categories: Biochemistry (medical) (Q1); Drug Discovery (Q1); Health Policy (Q1).
Verified field sources
- Journal Impact Factor: 7.0 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
- Impact Factor year: 2025 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
- Editor(s): Olga Golubnitschaja PhD, MD (Editor-in-Chief) — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
Source-backed journal facts
Topics in published research
Retinal Diseases and Treatments; Cardiovascular Health and Risk Factors; Glaucoma and retinal disorders; Nutrition, Genetics, and Disease; Health, Environment, Cognitive Aging; Gut microbiota and health.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
2,890.00 USD; 4,590.00 EUR
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Prostate cancer treatment costs increase more rapidly than for any other cancer—how to reverse the trend?
J. Ellinger, A. Alajati, P. Kubatka, F. A. Giordano et al.
2022-03 · DOI: 10.1007/s13167-022-00276-3Sleep duration and atrial fibrillation risk in the context of predictive, preventive, and personalized medicine: the Suita Study and meta-analysis of prospective cohort studies
Ahmed Arafa, Yoshihiro Kokubo, Keiko Shimamoto, Rena Kashima et al.
2022-03 · DOI: 10.1007/s13167-022-00275-4Evaluation of thermal sensitivity is of potential clinical utility for the predictive, preventive, and personalized approach advancing metabolic syndrome management
Sujeong Mun, Kihyun Park, Siwoo Lee
2022-03 · DOI: 10.1007/s13167-022-00273-6Muti-omics integration analysis revealed molecular network alterations in human nonfunctional pituitary neuroendocrine tumors in the framework of 3P medicine
Siqi Wen, Chunling Li, Xianquan Zhan
2022-03 · DOI: 10.1007/s13167-022-00274-5Predicting acupuncture efficacy for functional dyspepsia based on routine clinical features: a machine learning study in the framework of predictive, preventive, and personalized medicine
Tao Yin, Hui Zheng, Tingting Ma, Xiaoping Tian et al.
2022-03 · DOI: 10.1007/s13167-022-00271-8Metabolic phenotyping of tear fluid as a prognostic tool for personalised medicine exemplified by T2DM patients
Julia Brunmair, Andrea Bileck, Doreen Schmidl, Gerhard Hagn et al.
2022-03 · DOI: 10.1007/s13167-022-00272-7Functional metabolome profiling may improve individual outcomes in colorectal cancer management implementing concepts of predictive, preventive, and personalized medical approach
Yu Yuan, Chenxin Yang, Yingzhi Wang, Mingming Sun et al.
2022-03 · DOI: 10.1007/s13167-021-00269-8Development and validation of a transcriptomic signature-based model as the predictive, preventive, and personalized medical strategy for preterm birth within 7 days in threatened preterm labor women
Yuxin Ran, Jie He, Wei Peng, Zheng Liu et al.
2022-03 · DOI: 10.1007/s13167-021-00268-9Predictive factors, preventive implications, and personalized surgical strategies for bone metastasis from lung cancer: population-based approach with a comprehensive cancer center-based study
Xianglin Hu, Wending Huang, Zhengwang Sun, Hui Ye et al.
2022-03 · DOI: 10.1007/s13167-022-00270-9Modeling SARS-CoV-2 spike/ACE2 protein–protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context
Vincenzo Tragni, Francesca Preziusi, Luna Laera, Angelo Onofrio et al.
2022-03 · DOI: 10.1007/s13167-021-00267-wMass spectrometry analysis of human tear fluid biomarkers specific for ocular and systemic diseases in the context of 3P medicine
Xianquan Zhan, Jiajia Li, Yuna Guo, Olga Golubnitschaja et al.
2021-12 · DOI: 10.1007/s13167-021-00265-yHidden Markov model segmentation to demarcate trajectories of residual apnoea-hypopnoea index in CPAP-treated sleep apnoea patients to personalize follow-up and prevent treatment failure
Alphanie Midelet, Sébastien Bailly, Renaud Tamisier, Jean-Christian Borel et al.
2021-12 · DOI: 10.1007/s13167-021-00264-zPlasma complement C7 as a target in non-small cell lung cancer patients to implement 3P medicine strategies
Jae Gwang Park, Beom Kyu Choi, Youngjoo Lee, Eun Jung Jang et al.
2021-12 · DOI: 10.1007/s13167-021-00266-xIntegrative genomic analysis of PPP3R1 in Alzheimer’s disease: a potential biomarker for predictive, preventive, and personalized medical approach
Zhike Zhou, Jun Bai, Shanshan Zhong, Rongwei Zhang et al.
2021-12 · DOI: 10.1007/s13167-021-00261-2Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person
Lenka Koklesova, Alena Mazurakova, Marek Samec, Kamil Biringer et al.
2021-12 · DOI: 10.1007/s13167-021-00263-0Superficial temperature distribution patterns before and after physical activity in school children are indicative for personalized exercise coaching and disease prevention
Agnieszka Dębiec-Bąk, Anna Skrzek, Halina Podbielska, Olga Golubnitschaja et al.
2021-12 · DOI: 10.1007/s13167-021-00262-1Association of systemic inflammation indices with visual field loss progression in patients with primary angle-closure glaucoma: potential biomarkers for 3P medical approaches
Shengjie Li, Yichao Qiu, Jian Yu, Mingxi Shao et al.
2021-12 · DOI: 10.1007/s13167-021-00260-3N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer
Miaolong Lu, Hailun Zhan, Bolong Liu, Dongyang Li et al.
2021-12 · DOI: 10.1007/s13167-021-00259-wEarly gestational profiling of oxidative stress and angiogenic growth mediators as predictive, preventive and personalised (3P) medical approach to identify suboptimal health pregnant mothers likely to develop preeclampsia
Enoch Odame Anto, David Antony Coall, Otchere Addai-Mensah, Yaw Amo Wiafe et al.
2021-12 · DOI: 10.1007/s13167-021-00258-xPersonalization of medical treatments in oncology: time for rethinking the disease concept to improve individual outcomes
Mariano Bizzarri, Valeria Fedeli, Noemi Monti, Alessandra Cucina et al.
2021-12 · DOI: 10.1007/s13167-021-00254-1Reviews
Community Reviews
Version History
September 25, 2026 at 7:27 am
September 25, 2026